Metastasis biopsy

PROCEDURE3 trials

Sponsors

Gustave Roussy, Cancer Campus, Grand Paris, Institut Cancerologie de l'Ouest

Conditions

Breast CancerLung CancerMetastatic Castration Resistant Prostate Cancer Patients

Unknown Phase

Prostate Cancer Evaluation of TaRgets in Genito Urinary Screening Program

CompletedNCT01786031

Gustave Roussy, Cancer Campus, Grand ParisMetastatic Castration Resistant Prostate Cancer Patients

Start: 2012-12-31End: 2015-01-31Updated: 2016-02-08

Clinico-biological Data Collection Study of Metastatic Breast Cancer

Active, not recruitingNCT03958136

Institut Cancerologie de l'OuestBreast Cancer

Start: 2018-12-24End: 2036-12-30Target: 289Updated: 2025-08-17

Clinico-biological Data Collection Study of Metastatic Lung Cancer

RecruitingNCT04944030

Institut Cancerologie de l'OuestLung Cancer

Start: 2023-04-24End: 2031-10-31Target: 200Updated: 2025-12-08

Related Papers

PERCIST-like response assessment with FDG PET based on automatic segmentation of all lesions in metastatic breast cancer.

Journal of Clinical Oncology2022-06-01

Abstract OT1-20-01: Feasibility of creation of a clinico-biological database: A prospective longitudinal cohort study of metastatic breast cancer patients (epicuresein)

Cancer Research2022-02-15

The EPICURE study: a pilot prospective cohort study of heterogeneous and massive data integration in metastatic breast cancer patients

BMC Cancer2021-03-3110 citations

Vimentin and Ki67 expression in circulating tumour cells derived from castrate-resistant prostate cancer.

2016-02-2968 citations

Molecular characterization of heterogeneity in circulating tumor cells (CTCs) and tumor samples of metastatic castration-resistant prostate cancer (mCRPC) patients: The multicenter PETRUS program.

Journal of Clinical Oncology2015-03-01